Pegylated Interferon is an effective and well-tolerated cytroreductive agent in patients with myeloproliferative neoplasms aged over 60 years

Hannah Al-Yousuf,Samah Alimam,Jonathan Lambert,Jenny O'Nions,Andrew Wilson, Mallika Sekhar,Syeda Ahmed,Aisha Roble, Emma Shambrook

BRITISH JOURNAL OF HAEMATOLOGY(2022)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要